Small Molecule Program

About Interon Laboratories

Interon Laboratories is a private, pre-revenue biotech firm developing a first-in-class neuro-immunotherapy platform. Its core technology, rooted in foundational research from MIT and Harvard, aims to modulate the interaction between the nervous and immune systems to treat disorders across both domains. The company has two lead programs in development and is headquartered in Miami, with a research presence at the Blavatnik Harvard Life Lab in Boston. Interon represents a high-risk, high-reward venture targeting a significant unmet medical need with a novel therapeutic approach.

Therapeutic Areas

Other Neurological and Immune Disorders Drugs